Shiyanbola Olayinka O, Maurer Martha, Wen Meng-Jung
Division of Social and Administrative Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Sonderegger Research Center for Improved Medication Outcomes, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Pharmacy (Basel). 2022 Dec 21;11(1):2. doi: 10.3390/pharmacy11010002.
Due to diabetes disparities commonly seen among African Americans, it is important to address psychosocial and sociocultural barriers to medication adherence among African Americans with diabetes. Building on our prior work testing a culturally adapted peer supported diabetes self-management intervention for African Americans, this study will conduct a pilot randomized controlled feasibility trial that compares the culturally adapted intervention with a standard diabetes self-management program.
Using an intervention mixed-methods design, the six-month trial will be conducted at two sites. Twenty-four African Americans with uncontrolled type 2 diabetes will be randomized to the intervention or control arm. Feasibility and acceptability outcomes in four domains (recruitment, intervention acceptability, intervention adherence, retention) will be collected. Primary clinical outcome (A1C), secondary outcome (medication adherence) and patient-specific psychosocial measures will be collected at baseline, 2 months, and 6 months. Document review, interview and focus groups will be used to gather qualitative data on feasibility and acceptability.
Expected results are that the trial protocol will be feasible to implement and acceptable for participants, and there will be a signal of clinically meaningful reduction in A1C and improvements in medication adherence.
The results of this trial will inform a future powered large-scale randomized controlled trial testing the effectiveness of the culturally tailored intervention.
由于非裔美国人中常见的糖尿病差异,解决非裔美国糖尿病患者在药物依从性方面的心理社会和社会文化障碍很重要。基于我们之前对非裔美国人进行的一项经过文化调适的同伴支持糖尿病自我管理干预试验,本研究将开展一项试点随机对照可行性试验,比较经过文化调适的干预措施与标准糖尿病自我管理项目。
采用干预混合方法设计,为期六个月的试验将在两个地点进行。24名2型糖尿病控制不佳的非裔美国人将被随机分配到干预组或对照组。将收集四个领域(招募、干预可接受性、干预依从性、留存率)的可行性和可接受性结果。主要临床结局(糖化血红蛋白)、次要结局(药物依从性)和患者特定的心理社会指标将在基线、2个月和6个月时收集。将通过文件审查、访谈和焦点小组来收集关于可行性和可接受性的定性数据。
预期结果是试验方案实施可行且参与者可接受,并且会有糖化血红蛋白出现具有临床意义的降低以及药物依从性得到改善的迹象。
本试验结果将为未来一项检验文化调适干预有效性的大规模随机对照试验提供参考。